This compound is a pharmaceutical intermediate featuring a complex polycyclic heteroaromatic system with a sulfonyl group and a trifluoroethyl carboxamide moiety. It is primarily supplied for use in pharmaceutical research and manufacturing processes.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 2411540-30-0
N-desmethyl afatinib
Afatinib metabolite and impurity reference standard
(R)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((R)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutanamide
Pharmaceutical intermediate for afatinib impurities
Afatinib Impurity 18
Pharmaceutical impurity reference standard
(S,E)-2-((3-Chloro-4-fluorophenyl)(6-(4-(dimethylamino)but-2-enamido)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-yl)amino)malonic acid
Pharmaceutical intermediate for Afatinib impurities
8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3-tosyl-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
Pharmaceutical intermediate
(3S,4R)-3-ethyl-4-[5-(4-methylphenyl)sulfonyl-1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl]-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
KATSISSQDXODJA-AEFFLSMTSA-N
CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(N=C3)N(C=C4)S(=O)(=O)C5=CC=C(C=C5)C)C(=O)NCC(F)(F)F
—